172.61

1.67% -2.94

Agilent Technologies Inc (A)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$175.55

Aprire:

$175.04

Volume 24 ore:

891.54K

Relative Volume:

0.44

Capitalizzazione di mercato:

$48.66B

Reddito:

$7.23B

Utile/perdita netta:

$1.41B

Rapporto P/E:

34.67

EPS:

4.979

Flusso di cassa netto:

$1.09B

1 W Prestazione:

+1.21%

1M Prestazione:

+12.31%

6M Prestazione:

+45.97%

1 anno Prestazione:

+22.33%

Intervallo 1D:

$172.19

$177.47

Intervallo di 1 settimana:

$169.90

$177.04

Portata 52W:

$108.35

$177.47

Agilent Technologies Inc Stock (A) Company Profile

Nome

Agilent Technologies Inc

Settore

Healthcare (1051)

Industria

Diagnostics & Research (44)

Telefono

(408) 345-8886

Indirizzo

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Dipendente

18,100

Cinguettio

@agilent

Prossima data di guadagno

2026-11-23

Ultimi documenti SEC

A's Discussions on Twitter

Compare A vs TMO, DHR, NTRA, IDXX

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
A Agilent Technologies Inc	172.61	48.66B	7.23B	1.41B	1.09B	4.979
TMO Thermo Fisher Scientific Inc	688.07	254.41B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	229.04	161.01B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	391.63	56.45B	2.50B	-226.32M	71.51M	-1.6412
IDXX Idexx Laboratories Inc	559.13	44.05B	4.45B	1.10B	1.06B	13.59

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-09-09	Ripresa	UBS	Neutral
2026-07-09	Ripresa	Jefferies	Hold
2026-06-26	Ripresa	Bernstein	Outperform
2026-06-11	Iniziato	Piper Sandler	Neutral
2026-05-28	Aggiornamento	BofA Securities	Neutral → Buy
2026-05-27	Iniziato	RBC Capital Mkts	Outperform
2026-01-20	Iniziato	HSBC Securities	Buy
2026-01-05	Aggiornamento	Evercore ISI	In-line → Outperform
2025-12-15	Aggiornamento	Barclays	Equal Weight → Overweight
2025-12-09	Iniziato	Goldman	Buy
2025-12-02	Iniziato	Morgan Stanley	Overweight
2025-10-08	Iniziato	Rothschild & Co Redburn	Buy
2025-10-08	Aggiornamento	UBS	Neutral → Buy
2025-02-10	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-27	Downgrade	Wolfe Research	Outperform → Peer Perform
2024-06-03	Ripresa	Jefferies	Hold
2024-04-05	Aggiornamento	Stifel	Hold → Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Buy → Neutral
2023-11-17	Downgrade	UBS	Buy → Neutral
2023-09-28	Iniziato	Bernstein	Mkt Perform
2023-07-31	Downgrade	Evercore ISI	Outperform → In-line
2023-05-24	Reiterato	Barclays	Equal Weight
2023-05-24	Reiterato	BofA Securities	Buy
2023-05-24	Reiterato	Citigroup	Neutral
2023-05-24	Reiterato	Credit Suisse	Outperform
2023-05-24	Reiterato	Evercore ISI	Outperform
2023-05-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-24	Reiterato	Robert W. Baird	Outperform
2023-05-24	Reiterato	SVB Securities	Outperform
2023-05-24	Reiterato	Stifel	Hold
2023-05-24	Reiterato	TD Cowen	Outperform
2023-05-24	Reiterato	Wells Fargo	Overweight
2023-05-11	Iniziato	Barclays	Equal Weight
2023-01-10	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-20	Iniziato	UBS	Buy
2022-07-08	Downgrade	Citigroup	Buy → Neutral
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2022-02-23	Reiterato	BofA Securities	Buy
2022-02-23	Reiterato	Citigroup	Buy
2022-02-23	Reiterato	Cowen	Outperform
2022-02-23	Reiterato	Evercore ISI	Outperform
2022-02-23	Reiterato	Stifel	Hold
2022-02-23	Reiterato	Wells Fargo	Overweight
2021-11-23	Reiterato	BofA Securities	Buy
2021-11-23	Reiterato	Cowen	Outperform
2021-11-23	Reiterato	Stifel	Hold
2021-03-18	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Aggiornamento	BofA Securities	Neutral → Buy
2020-12-02	Iniziato	Goldman	Buy
2020-11-25	Aggiornamento	UBS	Neutral → Buy
2020-11-17	Aggiornamento	Cleveland Research	Neutral → Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-09-30	Iniziato	Atlantic Equities	Neutral
2020-08-19	Reiterato	BofA Securities	Neutral
2020-08-19	Reiterato	Citigroup	Neutral
2020-08-19	Reiterato	Jefferies	Buy
2020-08-19	Reiterato	Robert W. Baird	Outperform
2020-08-19	Reiterato	SVB Leerink	Outperform
2020-08-19	Reiterato	Stifel	Hold
2020-08-19	Reiterato	Wells Fargo	Overweight
2020-02-24	Downgrade	Needham	Buy → Hold
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-26	Reiterato	Needham	Buy
2019-11-15	Iniziato	Stifel	Hold
2019-10-18	Downgrade	UBS	Buy → Neutral
2019-07-16	Downgrade	BofA/Merrill	Buy → Neutral
2019-07-15	Downgrade	Barclays	Overweight → Equal Weight

Mostra tutto

Agilent Technologies Inc Borsa (A) Ultime notizie

Oct 14, 2026

Agilent Technologies (NYSE:A): Re‑Accelerating After a Two‑Year Soft Patch Thanks to the Backbone of Regulated Labs - Stocks Down Under

Oct 14, 2026

Philly-based AI medical analysis start-up to be acquired for up to $270 million - Inquirer.com

Oct 14, 2026

Agilent to buy Proscia for $240M - MedTech Dive

Oct 14, 2026

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist - Benzinga

Oct 14, 2026

Agilent to Acquire Proscia for Up to $270M to Build Scientific Intelligence Layer in Digital Pathology - HIT Consultant

Oct 14, 2026

Oct 13, 2026

Agilent Technologies to Acquire Proscia for Up to $270 Million to Expand AI-Powered Digital Pathology Business - citybiz

Oct 13, 2026

Agilent Technologies (A) Acquires Proscia to Expand Digital Path - GuruFocus

Oct 13, 2026

Agilent Technologies to Acquire Proscia in All-Cash Deal - marketscreener.com

Oct 13, 2026

Agilent Technologies to Acquire Proscia in All-Cash Deal - Yahoo Finance

Oct 13, 2026

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence - Business Wire

Oct 13, 2026

Agilent Technologies Inc. Research & Ratings | AGIL - Barron's

Oct 13, 2026

TD Cowen Adjusts Price Target on Agilent Technologies to $196 From $180 - www.marketscreener.com

Oct 13, 2026